You can multiply your capital many times over in the next five years, if you carefully invest in selective  biopharma opportunities today!  Many a slip between the cup and the lip... it all lies in understanding the fundamentals and investing in the promising companies that are developing advanced therapies. 

At Biovalues, we help you find the right therapy sectors with promise and identify the players that will win tomorrow. 

BioValues is a financial and technology advisory firm that specializes in biotechnology, pharmaceuticals, and the healthcare markets.  We provide advisory services to Investment Banks, Hedge funds, Big Pharma and equity investors, who are seeking high ROI biotech companies, both pre-IPO as well as listed small caps.  

BUSINESS

BioValues offers consulting and valuation services with an objective to facilitate and fund the right biotech ventures.  We have identified key opportunities ("finds") that have a high probability of winning and dominating the market in the next five years by virtue of their technologies, products, and services.  This is going to be accomplished only by a very small fraction of the players. 

BioValues has a short-list of such companies, both pre-IPO as well as listed, based on various criteria that we use to understand how the companies are positioned to bring effective therapeutic modalities to the market in a relatively short time, and their prospects with consumers in the long-term.

BioValues publishes a monthly biotech letter with late breaking industry events with a crisp analysis of their implications for any biotech investor. 

Please contact us with questions, comments or enquiries about our portfolio of services.  Click here to register to receive our informative monthly biotech letter.